These drugs can effectively fight against Omicron subvariant
Scientists from the University of Wisconsin-Madison found the antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer’s Paxlovid pill (nirmatrelvir), remain effective against...
Scientists find how COVID-19 attacks the heart
Scientists from the Bochum university hospital found how COVID-19 attack the heart.
In the study, the team found that SARS-Cov-2 infects human cardiac muscle cells...
COVID-19 vaccine can protect people of all body weights from death
Scientists from the University of Oxford found that COVID-19 vaccines have greatly reduced the number of cases of severe COVID-19 disease for everyone regardless...
Long COVID: female, older age and existing health problems increase risk
About 2 million people in the UK currently have long COVID, according to the latest data from the Office for National Statistics.
In the UK,...
COVID-19 infection may lead to testicular damage
Scientists from The University of Hong Kong found that the COVID19 virus can cause testicular damage, chronic asymmetric testicular atrophy, and hormonal changes.
They suggest...
New antiviral drug combo could effectively treat COVID-19
Scientists from the University of Pennsylvania found a powerful combination of antivirals to treat COVID-19.
They found combining the drug brequniar with remdesivir or molnupiravir—both...
COVID-19 can lead to kidney damage
Scientists from RWTH Uniklinik Aachen found the coronavirus SARS-CoV-2 infects the kidneys and contributes to tissue scarring.
The research is published in Cell Stem Cell...
Scientists find the cause of long COVID symptoms
Many who experience what is now called "long COVID" report feeling brain fog, breathless, fatigued and limited in doing everyday things, often lasting weeks...
Weight loss drugs may help stop COVID-19
Scientists from Oregon Health & Science University found the virus that causes COVID-19 undertakes a massive takeover of the body's fat-processing system.
This creates cellular...
Brain damage could be severer in COVID-19 than in Alzheimer’s disease
Scientists from NYU Grossman School of Medicine found people hospitalized for COVID-19 had higher levels of neurological damage than non-COVID-19 patients diagnosed with Alzheimer’s...